Crohn's disease: The cold chain hypothesis

Lancet

Volumn 362, Issue 9400, 2003, Pages 2012-2015

  Hugot, Jean Pierre ^a,b,c   Alberti, Corinne ^b   Berrebi, Dominique ^b   Bingen, Edouard ^b   Cézard, Jean Pierre ^b  

^a INSERM   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15;

ARTICLE; BACILLUS CEREUS; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIUM; BACTERIUM IDENTIFICATION; CLOSTRIDIUM BOTULINUM; COLD CHAIN HYPOTHESIS; CROHN DISEASE; DIET; ENVIRONMENTAL FACTOR; FAMILY HISTORY; FOOD FREEZING; FOOD PRESERVATION; GENE MUTATION; HUMAN; HYPOTHESIS; IMMUNE RESPONSE; INTESTINE; LIFESTYLE; LISTERIA MONOCYTOGENES; MEDICAL INFORMATION; MUCOSA; PATHOGENICITY; PERSONAL HYGIENE; PRIORITY JOURNAL; RISK ASSESSMENT; TEMPERATURE DEPENDENCE; YERSINIA ENTEROCOLITICA; YERSINIA PSEUDOTUBERCULOSIS;

EID: 0346734343     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)15024-6     Document Type: Note

References (40)

1. Podolsky D.K. Inflammatory bowel disease. N Engl J Med. 347:2002;417-429.
2. Hugot J.P., Chamaillard M., Zouali H., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 411:2001;599-603.
3. Ogura Y., Bonen D.K., Inohara N., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 411:2001;537-539.
4. Andus T., Gross V. Etiology and pathophysiology of Inflammatory Bowel Disease-environmental factors. Hepatogastroenterology. 47:2000;29-43.
5. Mayberry J.F., Rhodes J. Epidemiological aspects of Crohn's Disease: a review of the literature. Gut. 25:1984;886-899.
6. Rose J.D., Roberts G.M., Williams G., Mayberry J.F., Rhodes J. Cardiff Crohn's disease jubilee: the incidence over 50 years. Gut. 29:1988;346-351.
7. Fellows I.W., Freeman J.G., Holmes GKT. Crohn's disease in the city of Derby,1951-85. Gut. 31:1990;1262-1265.
8. Loftus E.V., Silverstein M.D., Sandborn W.J., Tremaine W.J., Harmsen W.S., Zinsmeister A.R. Crohn's Disease in Olmsted County, Minnesota, 1940-93: incidence, prevalence, and survival. Gastroenterology. 114:1998;1161-1168.
9. Gent A.E., Hellier M.D., Grace R.H., Swarbrick E.T., Coggon D. Inflammatory bowel disease and domestic hygiene in infancy. Lancet. 343:1994;766-767.
10. McCormick P., Manning D. Chronic inflammatory bowel disease and the "over clean" environment: rarity in the Irish traveller community. Ir Med J. 94:2001;203-204.
11. Karlinger K., Györke T., Mako E., Mester A., Tarjan Z. The epidemiology and the pathogenesis of inflammatory bowel disease. Eur J Radiol. 35:2000;154-167.
12. Hugot J.P., Cézard J.P., JF C., Belaiche J., et al. Clustering of Crohn's disease within affected sibships. Eur J Hum Genet. 11:2003;179-184.
13. Thévenot R. Essai pour une histoire du froid artificiel dans le monde. 1978;Paris, Institut International du froid.
14. Hellers G. Crohn's disease in the Stockholm county 1955-74: a study of epidemiology, results of surgical treatment, and long-term prognosis. Acta Chir Scand. 490 (suppl):1979;1-84.
15. Brahme F., Lindstrom C., Wenckert A. Crohn's disease in a defined population: an epidemiological study of incidence, prevalence, mortality, and secular trends in the city of Malmo, Sweden. Gastroenterology. 69:1975;342-351.
16. Champagne C.P., Laing R.R., Roy D., Assanta Mafu A. Psychrotrophs in dairy products: their effects and their control. Crit Rev Food Sci Nutr. 34:1994;1-30.
17. Liu Y., Van Kruiningen H.J., West A.B., Cartun R.W., Cortot A., Colombel J.F. Immunocytochemical evidence of Listeria, Escherichia coli and Streptococcus antigens in Crohn's Disease. Gastroenterology. 108:1995;1396-1404.
18. Walmsley R.S., Anthony A., Sim R., Pounder R.E., Wakefield A.J. Absence of Escherichia coli, Listeria monocytogenes and Klebsiella pneumoniae antigens within inflammatory bowel disease tissues. J Clin Pathol. 51:1998;657-661.
19. Chen W., Li D., Paulus B., Wilson I., Chadwick V.S. Detection of Listeria monocytogenes by polymerase chain reaction in intestinal mucosal biopsies from patients with inflammatory bowel disease and controls. J Gastroenterol Hepatol. 15:2000;1145-1150.
20. Chiba M., Fukushima T., Inoue S., Horie Y., Iizuka M., Masamune O. Listeria monocytogenes in Crohn's disease. Scand J Gastroenterol. 33:1998;430-434.
21. Swidsinski A., Ladhoff A., Pernthaler A., et al. Mucosal flora in inflammatory bowel disease. Gastroenterology. 122:2002;44-54.
22. Greenwood M.H. Human carriage of Yersinia species and incidence in foods. Contrib Microbiol Immunol. 13:1995;74-76.
23. Blaser M.J., Miller R.A., Lacher J., Singleton J.W. Patients with active Crohn's disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens. Gastroenterology. 87:1984;888-894.
24. Kalinowski F., Wassmer A., Hofmann M.A., et al. Prevalence of enteropathogenic bacteria in surgically treated chronic inflammatory bowel disease. Hepatogastroenterology. 45:1998;1552-1558.
25. Lamps L.W., Madhusudhan K.T., Havens J.M., et al. Pathogenic Yersinia DNA is detected in bowel and mesenteric lymph nodes from patients with Crohn's disease. Am J Surg Pathol. 27:2003;220-227.
26. Van Kruiningen H.J., Ganley L.M., Freda B.J. The role of Peyer's patches in the age-related incidence of Crohn's disease. J Clin Gastroenterol. 24:1997;470-475.
27. Polito J.M., Childs B., Mellits E.D., Tokayer A.Z., Harris M.L., Bayless T.M. Crohn's disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology. 111:1996;580-586.
28. Fujimura Y., Kamoi R., Iida M. Pathogenesis of aphtoid ulcers in Crohn's disease: correlative findings by magnifying colonoscopy, electron microscopy, and immunochemistry. Gut. 38:1996;724-732.
29. Gleason T.H., Patterson S.D. The pathology of Yersinia enterocolitica ileocolitis. Am J Surg Pathol. 6:1982;347-355.
30. Sukegawa Y., Kamiya S., Yagita A., Sugamata M., Atomi Y. Induction of auto-immune colitis by Yersinia enterocolitica 60-kilodalton Heat-Shock Protein. Scand J Gastroenterol. 35:2000;1188-1193.
31. Arnold G.L., Beaves M.R., Prvjdun V.O., Mook W.J. Preliminary study of ciprofloxacin in active Crohn's disease. Inflamm Bowel Dis. 8:2002;10-15.
32. Mollaret H.H. Fifteen centuries of Yersiniosis. Contrib Microbiol Immunol. 13:1995;1-4.
33. Sonnenberg A., McCarty D.J., Jacobsen S.J. Geographic variation of inflammatory bowel disease within the United States. Gastroenterology. 100:1991;143-149.
34. Shivananda S., Lennard-Jones J., Logan R., et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European collaborative study on inflammatory bowel disease (EC-IBD). Gut. 39:1996;690-697.
35. Zeng L., Anderson F.H. Seasonal change in the exacerbations of Crohn's Disease. Scand J Gastroenetrol. 31:1996;79-82.
36. Chamaillard M., Philpott D., Girardin S., et al. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci. 100:2003;3455-3460.
37. Schreiber S., Nikolaus S., Hampe J. Activation of nuclear factor kappa B inflammatory bowel disease. Gut. 42:1998;477-484.
38. Miceli-Richard C., Lesage S., Rybojad M., et al. CARD15 mutations in Blau syndrome. Nat Genet. 29:2001;19-20.
39. Orth K., Xu Z., Mudgett M.B., et al. Disruption of signalling by Yersinia effector YopJ, a ubiquitin-like protein protease. Science. 290:2000;1594-1597.
40. Orth K., Palmer L.E., Bao Z.O., et al. Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector. Science. 285:1999;1920-1923.